FACIAL REJUVENATION MARKET 132
TABLE 128 FACE REJUVENATION MARKET, THROUGH 2013 ($ MILLIONS) 133
BODY SHAPING MARKET 133
TABLE 129 BODY SHAPING MARKET, THROUGH 2013 ($ MILLIONS) 133
ANTI-AGING HAIR TREATMENT MARKET 133
TABLE 130 HAIR TREATMENT--GROWTH AND COLOR, THROUGH 2013 ($ MILLIONS) 134
DISEASE MAINTENANCE 134
FIGURE 17 PERCENT OF BOOMERS (AGE-ADJUSTED) REPORTING SELECTED CHRONIC CONDITIONS BY SEX, 2004-2005 (%) 135
TABLE 131 GLOBAL ANTI-AGING DRUGS AND DISEASE-SPECIFIC SUPPLEMENT MARKET, THROUGH 2013 ($ MILLIONS) 136
TABLE 132 GLOBAL DISEASE MAINTENANCE MARKET, THROUGH 2013 ($ MILLIONS) 136
TABLE 133 GLOBAL DISEASE MAINTENANCE MARKET BY REGION, THROUGH 2013 ($ MILLIONS) 137
BONE AND JOINT HEALTH 137
Arthritis 137
Osteoporosis 138
TABLE 134 GLOBAL BONE AND JOINT MARKET, THROUGH 2013 ($ MILLIONS) 139
TABLE 135 TOP OSTEOPOROSIS DRUG SALES, 2007 139
New Bone and Joint Care Anti-aging Products 139
TABLE 136 NEW PRODUCTS--BONE AND JOINT CARE 139
TABLE 136 (CONTINUED) 140
METABOLIC SYNDROME 141
TABLE 137 METABOLIC SYNDROME MARKET BY REGION, THROUGH 2013 ($ MILLIONS) 141
Overweight and Obesity 141
Competitive Development 142
TABLE 138 TOP ANTI-OBESITY DRUGS SALE, 2007 ($ MILLIONS) 142
TABLE 139 NEW ANTI-OBESITY PRODUCT LAUNCHES 142
TABLE 140 NEW RESEARCH FINDINGS FOR OBESITY TREATMENT MARKET 143
Diabetes 143
Oral Drugs for Diabetes 143
Insulin Injections are Classified According to Mode of Use 144
TABLE 141 TOP ORAL DIABETIC DRUGS BY SALES, 2007 ($ MILLIONS) 144
TABLE 142 U.S. FDA-APPROVED ORAL DIABETIC DRUGS BY DRUG CLASS 144
TABLE 142 (CONTINUED) 145
TABLE 143 TOP INSULIN PRODUCTS BY SALES, 2007 145
TABLE 144 NEW RESEARCH FINDINGS FOR DIABE
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |